Amaç: Diyabetin erken tanı ve takibi ile sonrasında gelişebilecek metabolik bozuklukların önlenmesinde aile hekimleri önemli bir yere sahiptir. Diyabetin erken dönemi olan bozulmuş açlık glukozu (BAG) ile lipid metabolizma bozukluğu birlikteliğini inceledik. Gereç ve Yöntemler: Retrospektif olan çalışmamıza aile hekimliği polikliniğine başvuran bilinen diyabeti, dislipidemisi, kardiyovasküler hastalığı olmayan 993 hasta dâhil edildi. Olguların demografik özellikleri, açlık kan glukozu (AKG), total kolesterol, trigliserid, yüksek yoğunluklu lipoprotein [high density lipoprotein (HDL)], düşük yoğunluklu lipoprotein [low density lipoprotein (LDL)] ve hemoglobin A1c (HbA1c) parametreleri değerlendirildi. Bulgular: Çalışmaya katılanların %67,9'u kadındı ve %41,6'sında BAG vardı. Olguların %35,4'ünde (n=352) LDL; %33,6'sında (n=334) total kolesterol; %26,2'sinde (n=260) trigliserid değerleri yüksek; %51,1'inde (n=507) HDL düşük olarak saptandı. BAG görülenlerde yaş ortalamalarının ve trigliseridin yüksek olma oranının, AKG düzeyi normal olanlardan yüksek olduğu görüldü (p<0,001) (p<0,001). Erkeklerde BAG görülme oranı kadınlardan daha yüksekti (p<0,05). BAG olanların HbA1c düzeyleri, AKG düzeyi normal olanlardan yüksekti (p<0,001). LDL düzeyi, total kolesterol düzeyi ve trigliserid düzeyi yüksek olan olguların yaş ortalamaları, normal değerlere sahip olanlardan yüksek saptandı (p<0,001). Trigliserid düzeyleri yüksek olan olguların HbA1c yüzdesi düzeyleri, normal olan olgulardan yüksekti (p<0,05). Sonuç: BAG döneminde glukoz metabolizması ile birlikte lipid metabolizma bozukluğunun da başlayabileceğine dair veriler saptanmıştır. Koruyucu hekimlik uygulamalarında, erken dönemde risk altındaki hastaları belirleyerek, glukoz ve lipid metabolizması açısından takiplerinin yapılması klinik önem taşıyabilir.
Anahtar Kelimeler: Diyabet; prediyabet; bozulmuş açlık glukozu; hiperlipidemi
Objective: Family physicians have an important place in early diagnosis and follow-up diabetes and prevention of metabolic disorders that may develop later. We examined the association of impaired fasting glucose (IFG) which is the early stage of diabetes, and lipid metabolism disorder. Material and Methods: Our retrospective study included 993 patients without known diabetes, dyslipidemia, cardiovascular disease who applied to Family medicine outpatient clinic. Demographic characteristics of the cases, fasting plasma glucose (FPG), total cholesterol, triglyceride, high density lipoprotein (HDL), low density lipoprotein (LDL) and hemoglobin A1c (HbA1c) parameters were evaluated. Result: Of the study participants, 67.9% were women and 41.6% had IFG. LDL in 35.4% (n=352) of cases; 33.6% (n=334) of total cholesterol; 26.2 % (n=260) had high triglyceride values; HDL was found to low in 51.1% (n=507). The rate of high triglyceride levels and mean age of patients with IFG were higher than those with normal FPG levels (p<0.001) (p<0.001). The incidence of IFG in men was higher than women (p<0.05). HbA1c levels of patients with IFG were higher than with normal FPG (p<0.001). The mean age of the patients with high LDL, total cholesterol and triglyceride levels were found higher than patients with normal values (p<0.001). The HbA1c levels of the cases with abnormal triglyceride levels were higher than those with normal levels (p<0.05). Conclusion: We observed data indicating that lipid metabolism disorder may start together with glucose metabolism in IFG period. In preventive medicine practices, it may be clinically important to identify patients at risk in early period and follow them in terms of glucose and lipid metabolism.
Keywords: Diabetes; prediabetes; impaired fasting glucose; hyperlipidemia
- DeFronzo RA, Ferrannini E, Zimmet P. International Textbook of Diabetes Mellitus. Vol. 2. 4th ed. Chichester: Wiley-Blackwell; 2015. [Crossref]
- GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-59. Erratum in: Lancet. 2017;390(10106):e38. [PubMed] [PMC]
- Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002;25(9):1551-6. [Crossref] [PubMed]
- Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al.; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169-80. [Crossref] [PubMed] [PMC]
- American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17-S38. [Crossref] [PubMed]
- Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine. 2015;48(2):371-93. [Crossref] [PubMed]
- Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953. [Crossref] [PubMed] [PMC]
- Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999-1008. [Crossref] [PubMed] [PMC]
- Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. 2018;25(9):771-82. [Crossref] [PubMed] [PMC]
- Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Curr Diab Rep. 2018;18(12):127. [Crossref] [PubMed] [PMC]
- TEMD Obezite, Lipid Metabolizması, Hipertansiyon Çalışma Grubu. Dislipidemi taraması. Dislipidemi Tanı ve Tedavi Kılavuzu 2021. 9. Baskı. Ankara: Miki Matbaacılık San. ve Tic. Ltd. Şti.; 2021. p.17-23 [Link]
- Yu S, Sun Z, Zheng L, Guo X, Yang H, Sun Y. Prevalence of diabetes and impaired fasting glucose in hypertensive adults in rural China: far from leveling-off. Int J Environ Res Public Health. 2015;12(11):14764-79. [Crossref] [PubMed] [PMC]
- Song J, Chen X, Jiang Y, Mi J, Zhang Y, Zhao Y, et al. Association and interaction analysis of lipid accumulation product with impaired fasting glucose risk: a cross-sectional survey. J Diabetes Res. 2019;2019:9014698. [Crossref] [PubMed] [PMC]
- Valentino G, Kramer V, Orellana L, Bustamante MJ, Casasbellas C, Adasme M, et al. Impaired fasting glucose in nondiabetic range: is it a marker of cardiovascular risk factor clustering? Dis Markers. 2015;2015:804739. [Crossref] [PubMed] [PMC]
- Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD; ARIC Study Investigators. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57(16):1690-6. [Crossref] [PubMed] [PMC]
- Menke A, Rust KF, Cowie CC. Diabetes based on 2-h plasma glucose among those classified as having prediabetes based on fasting plasma glucose or A1c. Diab Vasc Dis Res. 2018;15(1):46-54. [Crossref] [PubMed]
- Cui J, Sun J, Wang W, Xin H, Qiao Q, Baloch Z, et al. The association of triglycerides and total cholesterol concentrations with newly diagnosed diabetes in adults in China. Oncotarget. 2017;8:103477-85. [Crossref] [PubMed] [PMC]
- Tai ES, Goh SY, Lee JJ, Wong MS, Heng D, Hughes K, et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care. 2004;27(7):1728-34. [Crossref] [PubMed]
- Bennasar-Veny M, Fresneda S, López-González A, Busquets-Cortés C, Aguiló A, Ya-ez AM. Lifestyle and progression to Type 2 diabetes in a cohort of workers with prediabetes. Nutrients. 2020;12(5):1538. [Crossref] [PubMed] [PMC]
- Bergman M, Abdul-Ghani M, DeFronzo RA, Manco M, Sesti G, Fiorentino TV, et al. Review of methods for detecting glycemic disorders. Diabetes Res Clin Pract. 2020;165:108233. Erratum in: Diabetes Res Clin Pract. 2021;180:108632. [Crossref] [PubMed] [PMC]
- Rooney MR, Rawlings AM, Pankow JS, Echouffo Tcheugui JB, Coresh J, Sharrett AR, et al. Risk of progression to diabetes among older adults with prediabetes. JAMA Intern Med. 2021;181(4):511-9. Erratum in: JAMA Intern Med. 2021;181(4):570. [Crossref] [PubMed] [PMC]
.: Process List